@FierceMedDev: ICYMI yesterday: Edwards gains option to acquire startup CardioKinetix in $50M financing. Article | Follow @FierceMedDev
@EmilyWFierce: Stryker's OtisMed to pay more than $80M to settle DOJ case over knee replacement surgical devices. Story | Follow @EmilyWFierce
> Incoming Senate majority leader Mitch McConnell (R-KY) plans to address repealing the Affordable Care Act and medical device tax as soon as January. Story
> The NIH continues to participate in the Interagency National Robotics Initiative to back projects that could help with stroke rehabilitation, guide wheelchairs and assist children with autism spectrum disorder. News
> Cyberonics' clinical trial of its AspireSR generator found decreased seizure duration in epileptic patients. Release
> Aesthetic device company Syneron Medical signed a multiyear agreement with American Medical Systems, a pelvic health medtech company, to supply holmium lasers for the treatment of kidney stones. Release
Biotech News
@FierceBiotech: Bluebird posts more promising results with its rare disease therapy. Story | Follow @FierceBiotech
@DamianFierce: So the billionaire Russian oligarch who bought Watson's Nobel medal for $4.1 million is giving it back because hey. More | Follow @DamianFierce
> Pfizer strikes another immunotherapy deal to widen its oncology pipeline. News
> Lilly and Incyte's oral arthritis drug aces its first Phase III test. Story
> Circassia looks to higher doses to salvage ragweed drug after PhIIb miss. Article
Pharma News
@FiercePharma: Did Merck pay $3B too much for Cubist? Analysts weigh impact of Cubicin patent loss. Story | Follow @FiercePharma
@CarlyHFierce: AbbVie's Humira competition begins with Cadila's biosimilar launch in India. More | Follow @CarlyHFierce
> Long-term painkiller use on the rise, with more patients taking dangerous combos. Story
> J&J discount offer wins NICE over to new use for Stelara. Article
> Valeant temporarily swears off dealmaking to cut debt--and prove it's not desperate. News
Biotech Research News
> Epizyme showcases a successful preclinical lymphoma program for third target. More
> MicroRNA holds clues to predicting progression-free myeloma survival. Report
> New malaria drug unleashes an immune system assault on infected cells. Story
> Could alpha secretase offer a better approach to fighting Alzheimer's? More
> PKC-epsilon pathway offers a new line of attack against cancer cells. Article
Pharma Manufacturing News
> India's Zydus Cadila finds blood pressure med has embedded brown spots. Story
> Ferring preps for first U.S. plant opening as it moves to New Jersey campus. More
> FDA notches a win after Tennessee compounder pleads guilty. Report
> Meda drops Recipharm contract; plant may be forced to close. Story
> Daewoong inks deal to build $188M facility in South Korea. Article